Skip to content 
At DECODE-PD, we are not only developing new treatments—we are working to prevent Parkinson’s disease altogether. Treating symptoms is progress, but stopping the disease before it starts is the ultimate goal.
For the studies below, our aim is to recruit those individuals that do not have a Parkinson’s disease diagnosis.
NADage
The NADage study aims to investigate the potential of nicotinamide riboside (NR) in reducing physical and cognitive decline in the frail population, while improving clinical symptoms of frailty.
NADream
NADream aims to investigate the effects of NR on sleep quality in healthy adults. The hypothesis is that NR may improve the brain’s ability to “rest” during sleep, which may result in better sleep quality.
